Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels)...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Cheng, Gang, Zielonka, Jacek, Hardy, Micael, Ouari, Olivier, Chitambar, Christopher R., Dwinell, Michael B., Kalyanaraman, Balaraman
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2019
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544408/
https://ncbi.nlm.nih.gov/pubmed/31191823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26943
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items